COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
| Autor: | Detlef Zillikens, Michael Kasperkiewicz, K Mead, Andreas Recke, R Strong, David T. Woodley, M. Yale |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pemphigoid COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) business.industry Cross-sectional study Public health Foundation (evidence) COVID-19 Dermatology medicine.disease Pemphigus Cross-Sectional Studies Family medicine Cohort Pandemic Pemphigoid Bullous medicine Humans business |
| Zdroj: | The British journal of dermatologyReferences. 186(4) |
| ISSN: | 1365-2133 |
| Popis: | Patients with autoimmune bullous diseases (AIBDs) have faced considerable challenges during the COVID-19 outbreak.1 SARS-CoV-2 vaccines became an important public health solution, but the pandemic raised awareness of vaccine hesitancy.2 We aimed to investigate the currently unknown general vaccination status among AIBD patients to better inform vaccine practices in this cohort of potentially life-threatening inflammatory disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text